125 related articles for article (PubMed ID: 25098985)
41. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx.
Huber GF; Fritzsche FR; Züllig L; Storz M; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H
Int J Cancer; 2011 Sep; 129(6):1404-9. PubMed ID: 21105028
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Ries J; Agaimy A; Vairaktaris E; Kwon Y; Neukam FW; Strassburg LH; Nkenke E
Int J Oncol; 2012 Sep; 41(3):1085-93. PubMed ID: 22751922
[TBL] [Abstract][Full Text] [Related]
43. Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: A systematic review and meta-analysis.
Monteiro L; Mariano LC; Warnakulasuriya S
Oral Dis; 2024 Mar; 30(2):207-215. PubMed ID: 36103586
[TBL] [Abstract][Full Text] [Related]
44. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
45. High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.
Xu Y; Ogose A; Kawashima H; Hotta T; Ariizumi T; Li G; Umezu H; Endo N
Oncol Rep; 2011 Mar; 25(3):599-607. PubMed ID: 21234520
[TBL] [Abstract][Full Text] [Related]
46. The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma.
Mashhadiabbas F; Mahjour F; Mahjour SB; Fereidooni F; Hosseini FS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):240-50. PubMed ID: 22769410
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
48. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of podoplanin in oral cancer and its association with poor clinical outcome.
Yuan P; Temam S; El-Naggar A; Zhou X; Liu DD; Lee JJ; Mao L
Cancer; 2006 Aug; 107(3):563-9. PubMed ID: 16804930
[TBL] [Abstract][Full Text] [Related]
50. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
51. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
52. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
[TBL] [Abstract][Full Text] [Related]
53. Expression of podoplanin and ABCG2 in oral erythroplakia correlate with oral cancer development.
Feng JQ; Mi JG; Wu L; Ma LW; Shi LJ; Yang X; Liu W; Zhang CP; Zhou ZT
Oral Oncol; 2012 Sep; 48(9):848-52. PubMed ID: 22525603
[TBL] [Abstract][Full Text] [Related]
54. Podoplanin expression in oral potentially malignant disorders and oral squamous cell carcinoma.
A G D; Janardanan-Nair B; B R V
J Clin Exp Dent; 2017 Dec; 9(12):e1418-e1424. PubMed ID: 29410757
[TBL] [Abstract][Full Text] [Related]
55. Investigating the level of salivary endothelin-1 in premalignant and malignant lesions.
Nosratzehi T; Risbaf Fakour S; Alijani E; Salehi M
Spec Care Dentist; 2017 May; 37(3):134-139. PubMed ID: 28199027
[TBL] [Abstract][Full Text] [Related]
56. Minichromosome maintenance-2 (MCM2) expression differentiates oral squamous cell carcinoma from pre-cancerous lesions.
Razavi SM; Jafari M; Heidarpoor M; Khalesi S
Malays J Pathol; 2015 Dec; 37(3):253-8. PubMed ID: 26712671
[TBL] [Abstract][Full Text] [Related]
57. VEGF expression from human dysplastic or malignant oral epithelium may be related to mast cell density and the subsequent angiogenetic phenomena.
Michailidou EZ; Markopoulos AK; Antoniades DZ
Int J Oral Maxillofac Surg; 2012 Dec; 41(12):1467-73. PubMed ID: 22652447
[TBL] [Abstract][Full Text] [Related]
58. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions.
Poomsawat S; Buajeeb W; Khovidhunkit SO; Punyasingh J
J Oral Pathol Med; 2010 Nov; 39(10):793-9. PubMed ID: 20618617
[TBL] [Abstract][Full Text] [Related]
59. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
60. Expression of Podoplanin in Different Grades of Oral Squamous Cell Carcinoma.
Prasad B; Kashyap B; Babu GS; Kumar GR; Manyam R
Ann Med Health Sci Res; 2015; 5(4):299-304. PubMed ID: 26229720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]